Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
High-purity AOD-9604 for lipolysis and fat-metabolism research
People who dont produce enough intrinsic factor can become deficient
Post-injection skin inflammation and infections may occur due to unsanitary administration or a reaction to the medicine
Cognitive and mood improvements typically develop over the following one to two weeks
Originally developed by Metabolic Pharmaceuticals in Australia during the 1990s, this synthetic peptide was designed to harness growth hormones fat-mobilizing properties while avoiding the metabolic complications associated with full-length GH therapy
Under these conditions, reconstituted material is generally considered stable for up to 30 days
